inside

Non categorizzato

INSIGHTEC’S EXABLATE SYSTEM SPARES THE UTERUS WHEN TREATING UTERINE FIBROIDS

INSIGHTEC announced on Wednesday that the FDA has approved the relabeling of the Exablate system to treat women with symptomatic uterine fibroids who want to spare their uterus and maintain fertility. Exablate can now be used for both women who are “family complete” and those who still want to conceive. Link to article

More Articles

Non categorizzato
Non categorizzato

FDA OK’S CHANGES FOR INSIGHTEC’S EXABLATE

Font Resize